Videos Investors are learning that paying 20X sales is nothing if the growth numbers are right. Articles You May Like Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value Trump is the most pro-stock market president in history, Wharton’s Jeremy Siegel says Market Watch: How Trump’s Tariff Strategy Could Reshape This Rally David Einhorn to speak as the priciest market in decades gets even pricier postelection Hedge funds performed better under Democratic presidents than Republican ones, history shows